{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:45:54Z","timestamp":1790721954325,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974276"],"award-info":[{"award-number":["81974276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.crad.2023.01.010","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T20:24:47Z","timestamp":1675455887000},"page":"375-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The prognostic value of splenic abnormalities in pretreatment 18F-FDG PET\/CT in patients with complete response diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"78","author":[{"given":"S.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.crad.2023.01.010_bib1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.crad.2023.01.010_bib2","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00261-017-1454-3","article-title":"Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT","volume":"43","author":"Davidson","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"10.1016\/j.crad.2023.01.010_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/cancers14030713","article-title":"Radiomics features of the spleen as surrogates for CT-based lymphoma diagnosis and subtype differentiation","volume":"14","author":"Enke","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.crad.2023.01.010_bib4","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.3390\/curroncol28060390","article-title":"How to diagnose and treat CD5-positive lymphomas involving the spleen","volume":"28","author":"Cabecadas","year":"2021","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.crad.2023.01.010_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2214\/AJR.08.1160","article-title":"CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma","volume":"192","author":"de Jong","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.crad.2023.01.010_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ajh.26151","article-title":"2021 Update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management","volume":"96","author":"Susanibar-Adaniya","year":"2021","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.crad.2023.01.010_bib7","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.crad.2023.01.010_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.blre.2018.03.005","article-title":"Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI","volume":"32","author":"Wight","year":"2018","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.crad.2023.01.010_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10147-020-01807-6","article-title":"The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma","volume":"26","author":"Yamanaka","year":"2021","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.crad.2023.01.010_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.annonc.2020.11.019","article-title":"Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET\/CT","volume":"32","author":"Cottereau","year":"2021","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.crad.2023.01.010_bib11","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1002\/ctm2.221","article-title":"Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma","volume":"10","author":"Shen","year":"2020","journal-title":"Clin Transl Med"},{"issue":"6","key":"10.1016\/j.crad.2023.01.010_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.crad.2023.01.010_bib13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.crad.2023.01.010_bib14","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.crad.2023.01.010_bib15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ajh.25493","article-title":"Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma","volume":"94","author":"St-Pierre","year":"2019","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.crad.2023.01.010_bib16","doi-asserted-by":"crossref","first-page":"e0186674","DOI":"10.1371\/journal.pone.0186674","article-title":"Splenomegaly\u2014diagnostic validity, work-up, and underlying causes","volume":"12","author":"Curovic Rotbain","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.crad.2023.01.010_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2967\/jnumed.117.193011","article-title":"(18)F-FDG PET and CT scans detect new imaging patterns of response and progression in patients with Hodgkin lymphoma treated by anti-programmed death 1 immune checkpoint inhibitor","volume":"59","author":"Dercle","year":"2018","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.crad.2023.01.010_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.sult.2006.10.010","article-title":"Lymphoma of the spleen","volume":"28","author":"Bhatia","year":"2007","journal-title":"Semin Ultrasound CT MR"},{"issue":"23","key":"10.1016\/j.crad.2023.01.010_bib19","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.crad.2023.01.010_bib20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/bjc.2016.325","article-title":"NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients","volume":"115","author":"Prochazka","year":"2016","journal-title":"Br J Cancer"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926023000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926023000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:47:35Z","timestamp":1757868455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926023000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0009926023000454"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2023.01.010","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of splenic abnormalities in pretreatment 18F-FDG PET\/CT in patients with complete response diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2023.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}